ARF6 and malignant colon neoplasm: In colon cancer cells, ACAP2, a downstream effector of Rab35, and also GTPase activating proteins (GAP) of ARF6, inhibits ARF6 and thus inhibits epithelial-mesenchymal transition (EMT) of tumor cells (Allaire et al., 2013).